IGMS: IGM Biosciences, Inc. Stock

by  •  • Comments Off on IGMS: IGM Biosciences, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 43.06
Enterprise Value ($M) 6.18
Book Value ($M) 0.70
Book Value / Share 0.02
Price / Book 61.69
NCAV ($M) -45.15
NCAV / Share -1.30
Price / NCAV -0.95

Profitability (mra)
Return on Invested Capital (ROIC) -4.45
Return on Assets (ROA) -0.53
Return on Equity (ROE) -1.23

Liquidity (mrq)
Quick Ratio 5.71
Current Ratio 5.71

Balance Sheet (mrq) ($M)
Current Assets 161.04
Assets 206.89
Liabilities 206.19
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2.68
Operating Income -194.22
Net Income -195.79
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -153.00
Cash from Investing 64.16
Cash from Financing 2.39

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Price T Rowe Associates Inc /md/ 10.50
11-12 13G/A Fmr Llc 2.42 -51.75
08-02 13G/A Invus Global Management, LLC 9.90

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-13 10-Q Table of Contents Condensed Balance Sheets Condensed Statements of Operations Condensed Statements of Comprehensive Loss Condensed Statements of Stockholders’ Equity Condensed Statements of Cash Flows Note 1. Organization Note 2. Summary of Significa
2025-04-30 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A
2025-03-06 10-K Annual Report on Form 10-K for the fiscal year ended December 31, 2024
2024-11-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-28 13,492 66,906 20.17
2025-05-27 14,330 91,302 15.70
2025-05-23 43,801 178,664 24.52

(click for more detail)

Similar Companies
IDXX – IDEXX Laboratories, Inc. IDYA – IDEAYA Biosciences, Inc.
IFRX – InflaRx N.V. IMUX – Immunic, Inc.
IMVT – Immunovant, Inc.


Financial data and stock pages provided by
Fintel.io